At a Senate hearing that considered her nomination to the post of NIH director, Monica Bertagnolli laid out an agenda that includes expanding access to clinical trials and making health care innovation affordable and accessible to the public.
Thyme Care announced the close of a $95 million capital raise. With $55 million in equity funding, Thyme Care welcomes new investor Concord Health Partners with participation from all existing investors, including CVS Health Ventures, Town Hall Ventures, a16z Bio + Health, AlleyCorp, Echo Health Ventures, Frist Cressey Ventures, and Foresite Capital.
